Ben Tempel

Ben Tempel is a highly experienced executive in the fields of cell and gene therapy, currently serving as CEO at HBVTECH and involved in strategy at PANTHERx Rare Pharmacy. With a background as Principal at Frameshift Advisors and Strategic Advisor at Expression Therapeutics, Inc., Ben has significantly contributed to corporate strategy and development during tenure as Vice President at AnovoRx and Director of Strategy at TruGreen. Prior roles include Director of Strategy and Planning at Accredo and Director of Development at Sunrise Senior Living. Ben's educational credentials include a Master of Science candidacy in Regenerative and Stem Cell Technologies from The Johns Hopkins University, an MBA from Emory University, dual Bachelor's degrees in Civil and Industrial Engineering from Georgia Institute of Technology, and certificates in Genetics and Genomics and Functional Genomics from Stanford and Harvard Medical School, respectively.